Search by Drug Name or NDC
NDC 70934-0634-95 Ondansetron 4 mg/1 Details
Ondansetron 4 mg/1
Ondansetron is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. dba Northwind Pharmaceuticals. The primary component is ONDANSETRON.
Product Information
NDC | 70934-0634 |
---|---|
Product ID | 70934-634_c7062955-792b-3de2-e053-2995a90af012 |
Associated GPIs | 50250065007220 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Ondansetron |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Ondansetron |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, ORALLY DISINTEGRATING |
Route | ORAL |
Active Ingredient Strength | 4 |
Active Ingredient Units | mg/1 |
Substance Name | ONDANSETRON |
Labeler Name | Denton Pharma, Inc. dba Northwind Pharmaceuticals |
Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA090469 |
Listing Certified Through | n/a |
Package
NDC 70934-0634-95 (70934063495)
NDC Package Code | 70934-634-95 |
---|---|
Billing NDC | 70934063495 |
Package | 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-634-95) |
Marketing Start Date | 2020-08-31 |
NDC Exclude Flag | N |
Pricing Information | N/A |